KLOR-CON Drug Patent Profile
Which patents cover Klor-con, and what generic alternatives are available?
Klor-con is a drug marketed by Upsher Smith Labs and Twi Pharms and is included in five NDAs.
The generic ingredient in KLOR-CON is potassium chloride. There is one drug master file entry for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Klor-con
A generic version of KLOR-CON was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KLOR-CON?
- What are the global sales for KLOR-CON?
- What is Average Wholesale Price for KLOR-CON?
Summary for KLOR-CON
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 308 |
| Patent Applications: | 3,666 |
| Drug Prices: | Drug price information for KLOR-CON |
| Drug Sales Revenues: | Drug sales revenues for KLOR-CON |
| What excipients (inactive ingredients) are in KLOR-CON? | KLOR-CON excipients list |
| DailyMed Link: | KLOR-CON at DailyMed |
Pharmacology for KLOR-CON
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
US Patents and Regulatory Information for KLOR-CON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | KLOR-CON | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 203106-001 | Jul 10, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Upsher Smith Labs | KLOR-CON | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 019123-002 | Apr 17, 1986 | AB2 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Twi Pharms | KLOR-CON | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 218979-001 | Oct 28, 2024 | AB2 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Upsher Smith Labs | KLOR-CON M10 | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 074726-002 | Aug 9, 2000 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Upsher Smith Labs | KLOR-CON | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 203106-002 | Jul 10, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
